ClinicalTrials.Veeva

Menu

Influence of Beta Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction

C

Chongqing Medical University

Status

Unknown

Conditions

AMI

Treatments

Drug: Beta blocker

Study type

Observational

Funder types

Other

Identifiers

NCT04485988
2020-06-25

Details and patient eligibility

About

To understand the effect of beta blockers on the prognosis of patients with acute myocardial infarction with preserved ejection fraction.

Full description

The use of beta blockers is an important component of drug therapy for myocardial infarction, but in some exceptional cases, evidence-based evidence for their use is insufficient, and we seek to understand the prognostic impact of beta blockers on patients enrolled in long-term follow-up.

Enrollment

3,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with acute myocardial infarction

Exclusion criteria

  • Previous history of heart failure admission Killip class > I class cancer pregnant

Trial design

3,000 participants in 2 patient groups

No-beta blocker
beta blocker
Treatment:
Drug: Beta blocker

Trial contacts and locations

1

Loading...

Central trial contact

dongying zhang, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems